Feedback / Questions
VTX3232 - Ventyx Biosci
https://www.globenewswire.com/news-release/2025/06/17/3100504/0/en/Ventyx-Biosciences-Announces-Positive-Top-Line-Data-from-its-Phase-2a-Safety-and-Biomarker-Trial-Evaluating-VTX3232-in-Patients-with-Early-Stage-Parkinson-s-Disease.html
Jun 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next